The BioRefinex thermal hydrolysis technology journey has been a long one that started with our founder, Dr. Erick Schmidt and his vision of improving the world and making it more sustainable. The technology has been independently reviewed and validated by a number of major institutions around the world:
The BioRefinex technology has been independently reviewed and validated by a number of major institutions around the world. Firstly, a research program began during the 1990s with independent testing conducted by The Roslin Institute, a world-renowned research organization located in Edinburgh, Scotland. They successfully completed multi-year live animal testing and validation of the thermal hydrolysis process in 2009. Their results are published in Process Biochemistry (Volume 44, Issue 9, September 2009, Pages 1060-1062), which is a European peer-reviewed scientific journal.
The BioRefinex thermal hydrolysis process has been approved by the Canadian Food Inspection Agency (CFIA) as a destructive process for the treatment of Specific Risk Material (SRM). Accordingly, the output from the process would not be subject to further SRM handling restrictions. Of the current CFIA-accepted methods for destruction (incineration, alkaline hydrolysis, and thermal hydrolysis) only thermal hydrolysis contributes to a sustainable environment.
The World Organization for Animal Health (OIE) adopted the BioRefinex technology as a recommended process for the destruction of all transmissible spongiform encephalopathy and microbiological disease agents in May 2010. The 175 member countries of the OIE formally approved the technology at the 78th General Session held in Paris for incorporation into the 2010 Terrestrial Animal Health Code. Specific reference can be found in chapter 4.12.6.10 of the Code, which is posted on the OIE Website.
The BioRefinex process is approved by the European Commission for the processing of all Category 2 materials (farm deadstock) and Category 3 inedible materials from packing plants. Based on the Roslin Institute test results and the OIE approval, a submission will now be made to the European Commission for approval of Category 1 material processing (BSE prion risk material).
